Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Principal Healthcare Innovators ETF (BTEC)

    Price:

    39.49 USD

    ( + 0.40 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    BTEC
    Name
    Principal Healthcare Innovators ETF
    Industry
    Asset Management
    Sector
    Financial Services
    Price
    39.490
    Market Cap
    16.190M
    Enterprise value
    Currency
    USD
    Ceo
    Full Time Employees
    Website
    Ipo Date
    2016-08-22
    City
    Des Moines
    Address

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    ProShares UltraShort Nasdaq Biotechnology

    VALUE SCORE:

    9

    Symbol
    BIS
    Market Cap
    0
    Industry
    Asset Management
    Sector
    Financial Services

    2nd position

    SuRo Capital Corp.

    VALUE SCORE:

    13

    Symbol
    SSSS
    Market Cap
    230.844M
    Industry
    Asset Management
    Sector
    Financial Services

    The best

    SuRo Capital Corp. 6.00% Notes due 2026

    VALUE SCORE:

    13

    Symbol
    SSSSL
    Market Cap
    230.844M
    Industry
    Asset Management
    Sector
    Financial Services
    FUNDAMENTALS
    P/E
    P/S
    P/B
    Debt/Equity
    EV/FCF
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    Earnings yield
    Debt/assets
    FUNDAMENTALS
    Net debt/ebidta
    Interest coverage
    Research And Developement To Revenue
    Intangile to total assets
    Capex to operating cash flow
    Capex to revenue
    Capex to depreciation
    Return on tangible assets
    Debt to market cap
    Piotroski Score
    FUNDAMENTALS
    PEG
    P/CF
    P/FCF
    RoA %
    RoIC %
    Gross Profit Margin %
    Quick Ratio
    Current Ratio
    Net Profit Margin %
    Net-Net
    FUNDAMENTALS PER SHARE
    FCF per share
    Revenue per share
    Net income per share
    Operating cash flow per share
    Free cash flow per share
    Cash per share
    Book value per share
    Tangible book value per share
    Shareholders equity per share
    Interest debt per share
    TECHNICAL
    52 weeks high
    52 weeks low
    Current trading session High
    Current trading session Low
    DIVIDEND
    Dividend yield
    undefined%
    Payout ratio
    undefined%
    Years of div. Increase
    Years of div.
    Q-shift
    Dividend per share
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0.008418561%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0.0049388306%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Asset Management
    Dividend yield
    0.05175744%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    DESCRIPTION

    Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.

    NEWS
    https://images.financialmodelingprep.com/news/finding-opportunity-in-unloved-healthcare-etfs-20240531.jpg
    Finding Opportunity in Unloved Healthcare ETFs

    etftrends.com

    2024-05-31 11:02:12

    Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

    https://images.financialmodelingprep.com/news/value-etf-investing-to-shine-as-sector-rotation-looks-20230725.jpg
    Value ETF Investing to Shine as Sector Rotation Looks Likely?

    zacks.com

    2023-07-25 09:22:35

    As rising rates are in the cards, value stocks are likely to take a center stage in the near term.

    https://images.financialmodelingprep.com/news/can-health-care-stocks-outperform-again-in-2023-20230111.jpg
    Can Health Care Stocks Outperform Again In 2023?

    seekingalpha.com

    2023-01-11 18:09:00

    How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

    https://images.financialmodelingprep.com/news/build-off-growth-in-healthcare-innovation-with-btec-20220203.jpg
    Build Off Growth in Healthcare Innovation With BTEC

    etftrends.com

    2022-02-03 15:08:37

    If the ongoing pandemic has taught anything, it's the need for healthcare innovation. That's exactly what the Principal Healthcare Innovators ETF (BTEC) is all about.

    https://images.financialmodelingprep.com/news/can-biotech-etfs-gain-from-positive-booster-update-20211021.jpg
    Can Biotech ETFs Gain From Positive Booster Update?

    zacks.com

    2021-10-21 17:24:02

    In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

    https://images.financialmodelingprep.com/news/biotech-etfs-to-benefit-from-latest-booster-update-20210820.jpg
    Biotech ETFs to Benefit From Latest Booster Update

    zacks.com

    2021-08-20 18:18:04

    The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

    https://images.financialmodelingprep.com/news/etf-odds-ends-2-active-esg-funds-debut-20210812.jpg
    ETF Odds & Ends: 2 Active ESG Funds Debut

    etf.com

    2021-08-12 13:44:41

    Two ESG-related ETFs launched this week, and both are heavy on the 'E.'

    https://images.financialmodelingprep.com/news/delta-variant-surge-brings-biotech-etfs-in-focus-20210803.jpg
    Delta Variant Surge Brings Biotech ETFs in Focus

    zacks.com

    2021-08-03 18:18:05

    The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

    https://images.financialmodelingprep.com/news/4-etf-areas-surged-last-week-20210614.jpg
    4 ETF Areas Surged Last Week

    zacks.com

    2021-06-14 13:32:03

    These four ETF areas were winners last week.

    https://images.financialmodelingprep.com/news/topperforming-biotech-etfs-of-last-week-20210614.jpg
    Top-Performing Biotech ETFs of Last Week

    zacks.com

    2021-06-14 12:02:07

    Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.

    https://images.financialmodelingprep.com/news/goldman-sachs-likes-these-health-tech-stocks-20210609.jpg
    Goldman Sachs Likes These Health Tech Stocks

    etftrends.com

    2021-06-09 14:27:42

    Broadly speaking, the healthcare sector is generally viewed as defensive, but there growing pockets of disruption and innovation in the space, including health technology equities. For investors looking for healthcare with a growth feel, the Principal Healthcare Innovators Index ETF (BTEC) is one exchange traded fund to consider.

    https://images.financialmodelingprep.com/news/top-covid19-vaccine-stories-of-may-put-biotech-etfs-20210601.jpg
    Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus

    zacks.com

    2021-06-01 16:32:03

    Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.

    https://images.financialmodelingprep.com/news/biotech-etfs-to-suffer-as-us-backs-ip-waiver-20210507.jpg
    Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines

    zacks.com

    2021-05-07 18:02:02

    The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

    https://images.financialmodelingprep.com/news/top-covid19-vaccine-stories-of-april-put-biotech-etfs-20210504.jpg
    Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus

    zacks.com

    2021-05-04 16:32:02

    Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

    https://images.financialmodelingprep.com/news/investing-for-tomorrow-today-exploring-the-future-of-health-care-20210428.jpg
    Investing for Tomorrow, Today: Exploring the Future of Health Care

    etftrends.com

    2021-04-28 18:27:34

    In the upcoming webcast, Investing for tomorrow, today: Exploring the future of health care, Steve Jones, Client Portfolio Manager, Principal Global Systematic Solutions; Jeffrey Schwarte, Portfolio Manager and Head of Systematic Solutions, Principal Global Systematic Solutions; and Matthew Cohen, Head of ETF Specialist Team, Principal Global Investors, will highlight the healthcare and technology investment themes [...] The post Investing for Tomorrow, Today: Exploring the Future of Health Care appeared first on ETF Trends.

    https://images.financialmodelingprep.com/news/biotech-innovations-remain-at-forefront-20210416.jpg
    Biotech Innovations Remain At Forefront

    seekingalpha.com

    2021-04-16 11:10:18

    The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.